Related Experiment Video

Updated: Jun 24, 2026

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
11:07

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

Cryptococcal lung disease

Rhett M Shirley1, John W Baddley

  • 1Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama 35294-0006, USA.

Current Opinion in Pulmonary Medicine
|April 9, 2009
PubMed
Abstract

Insights

Cryptococcal lung disease, an opportunistic fungal infection, is often underdiagnosed. Treatment varies based on severity and immune status, with fluconazole for mild cases and combination therapy for severe infections.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Cryptococcosis is a significant opportunistic fungal infection, particularly affecting immunocompromised individuals.
  • While cryptococcal meningitis is common, pulmonary cryptococcosis is likely underdiagnosed.
  • Understanding the epidemiology, diagnosis, and treatment of cryptococcal lung disease is crucial.

Purpose of the Study:

  • To review the current knowledge on cryptococcal lung disease.
  • To highlight the variability in clinical presentation and diagnosis.
  • To outline treatment strategies based on patient immune status and disease severity.

Main Methods:

  • Literature review of clinical trials and treatment guidelines.
  • Analysis of patient immune status and disease severity in relation to treatment outcomes.
  • Synthesis of current recommendations for managing pulmonary cryptococcosis.

Main Results:

  • Cryptococcal lung disease presents a spectrum from asymptomatic infection to severe pneumonia.
  • Clinical manifestations are diverse and influenced by the patient's immune status.
  • Limited treatment data exists for pulmonary cryptococcosis compared to meningitis, necessitating tailored approaches.

Conclusions:

  • Cryptococcal lung disease is an important, potentially underdiagnosed infection.
  • Effective management requires knowledge of epidemiology, diagnostics, and tailored treatment.
  • Optimizing patient outcomes depends on accurate diagnosis and appropriate therapeutic interventions.

More Related Videos

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation